Coding the Impossible Cure-Docuthon Insilico Presents @InsilicoMedicine
Coding the Impossible Cure-Docuthon Insilico Presents  @InsilicoMedicine
Uploaded June 2024 | Updated September 2026, 1 week ago
Insilico presents their in-house participation in the Docuthon contest. The creator, Larry Zhang, is responsible for the entity's video content. "As a filmmaker and artist, I once perceived science as confined to numbers and calculations, lacking in the exploration of dreams, emotions, and romance. However, as I sifted through the footage, I discovered that experts in AI and drug development possess even more curiosity, creativity, and passion to their craft. The success of Insilico Medicine isn’t solely attributed to the advancement of AI. it’s the individuals collaborating, imagining, leaping without safety ropes who bridged the gap between a novel technology and a finely tuned methodology. As I delved deeper into crafting the story, I came to realize that generative AI serves as the nexus where art and science converge from opposite ends of a circular spectrum. The overarching concept revolves around utilizing AI to heal humanity and extend healthy longevity."
Coding the Impossible Cure-Docuthon Insilico PresentsPharma.AI - the platform for target discovery, drug design, and clinical trial predictionNVIDIA founder and CEO Jensen Huang GTC Keynote on Generative AIPharma.AI Global LaunchRevolutionizing Drug Discovery with AI-Powered InnovationBenchmark DiscoveryAI-powered Drug Discovery lecture by Dr. Michael Levitt, 2013 Nobel Laureate in ChemistryInsilico Medicines first AI-discovered antifibrotic drug goes first-in-humanIntroducing nach0: A one-stop LLM for chemical and biomedical tasksO3DC - Open Drug Discovery and Development Consortium. Hear from the Experts.Insilico Deployed the First Bipedal Humanoid at the AI-Powered Fully-Automated LabIntroduction of PandaOmics for Target Discovery in Amyotrophic Lateral Sclerosis patients
Insilico Medicine |

Coding the Impossible Cure-Docuthon Insilico Presents

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER